Paris Kosmidis

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Geographic Areas

Greece

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Triantafillidis John K; Nasioulas Georgios; Kosmidis Paris A
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Linardou Helena; Dahabreh Issa J; Bafaloukos Dimitrios; Kosmidis Paris; Murray Samuel
Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC.
Fountzilas G; Dafni U; Dimopoulos M A; Koutras A; Skarlos D; Papakostas P; Gogas H; Bafaloukos D; Kalogera-Fountzila A; Samantas E; Briasoulis E; Pectasides D; Maniadakis N; Matsiakou F; Aravantinos G; Papadimitriou C; Karina M; Christodoulou C; Kosmidis P; Kalofonos H P
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Paris Kosmidis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Triantafillidis John K; Nasioulas Georgios; Kosmidis Paris A
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Anticancer research 2009;29(7):2727-37.
2009: Linardou Helena; Dahabreh Issa J; Bafaloukos Dimitrios; Kosmidis Paris; Murray Samuel
Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC.
Nature reviews. Clinical oncology 2009;6(6):352-66.
2009: Fountzilas G; Dafni U; Dimopoulos M A; Koutras A; Skarlos D; Papakostas P; Gogas H; Bafaloukos D; Kalogera-Fountzila A; Samantas E; Briasoulis E; Pectasides D; Maniadakis N; Matsiakou F; Aravantinos G; Papadimitriou C; Karina M; Christodoulou C; Kosmidis P; Kalofonos H P
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.
Breast cancer research and treatment 2009;115(1):87-99.
2009: Fountzilas George; Bamias Aristotelis; Kalogera-Fountzila Anna; Karayannopoulou Georgia; Bobos Mattheos; Athanassiou Eleni; Kalogeras Konstantine T; Tolis Christos; Tsekeris Periklis; Papakostas Pavlos; Vamvouka Chrysanthi; Zaramboukas Thomas; Kosmidis Paris; Zamboglou Nikolaos; Misailidou Despina
Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.
Anticancer research 2009;29(2):529-38.
2008: Fountzilas George; Bobos Mattheos; Kalogera-Fountzila Anna; Xiros Nikolaos; Murray Samuel; Linardou Helena; Karayannopoulou Georgia; Koutras Angelos K; Bafaloukos Dimitrios; Samantas Epaminondas; Christodoulou Christos; Economopoulos Theofanis; Kalogeras Konstantine T; Kosmidis Paris
Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation.
Cancer investigation 2008;26(8):784-93.
2008: Aravantinos Gerasimos; Fountzilas George; Bamias Aristotelis; Grimani Irene; Rizos Spyridon; Kalofonos Haralabos P; Skarlos Dimosthenis V; Economopoulos Theofanis; Kosmidis Paris A; Stathopoulos George P; Briasoulis Evangelos; Pectasides Dimitrios; Samantas Epaminondas; Timotheadou Eleni; Papadimitriou Christos; Papanikolaou Alexandros; Onyenadum Adimchi; Papakostas Pavlos; Bafaloukos Dimitrios; Dimopoulos Meletios A;
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2169-77.
2008: Koutras Angelos K; Fountzilas George; Dafni Urania; Dimopoulos Meletios A; Pectasides Dimitrios; Klouvas George; Papakostas Pavlos; Kosmidis Paris; Samantas Epaminondas; Gogas Helen; Briasoulis Evangelos; Vourli Georgia; Petsas Theodoros; Xiros Nikolaos; Kalofonos Haralabos P;
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.
Anticancer research 2008;28(5B):2913-20.
2008: Murray Samuel; Dahabreh Issa J; Linardou Helena; Manoloukos Menelaos; Bafaloukos Dimitrios; Kosmidis Paris
Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical database.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(8):832-9.
2008: Apessos Angela; Papadopoulou Eirini; Belogianni Ioulia; Baratsis Sotiris; Triantafillidis John K; Kosmidis Paris; Karydas Eirini; Briasoulis Evangelos; Pisiotis Christos; Papazisis Kostas; Nasioulas George
Inherited cancer predisposition syndromes in Greece.
Anticancer research 2008;28(2B):1341-7.
2008: Kosmidis P A; Kalofonos H P; Christodoulou C; Syrigos K; Makatsoris T; Skarlos D; Bakogiannis C; Nicolaides C; Bafaloukos D; Bamias A; Samantas E; Xiros N; Boukovinas I; Fountzilas G; Dimopoulos M A
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):115-22.
2008: Razis Evangelia; Briasoulis Evangelos; Vrettou Eleni; Skarlos Dimosthenis V; Papamichael Dimitrios; Kostopoulos Ioannis; Samantas Epaminontas; Xanthakis Ioannis; Bobos Mattheos; Galanidi Eleni; Bai Maria; Gikonti Ioanna; Koukouma Alona; Kafiri Georgia; Papakostas Pavlos; Kalogeras Konstantine T; Kosmidis Paris; Fountzilas George
Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study.
BMC cancer 2008;8():234.
2007: Timotheadou Eleni; Skarlos Dimosthenis-Vasilios; Samantas Epaminondas; Papadopoulos Savvas; Murray Sam; Skrickova Jana; Christodoulou Christos; Papakostantinou Christos; Pectasides Dimitrios; Papakostas Pavlos; Kaplanova Jana; Vrettou Eleni; Karina Maria; Kosmidis Paraskevas; Fountzilas George
Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
Anticancer research 2007;27(6C):4481-9.
2007: Kosmidis P; Fountzilas G; Baka S; Samantas E; Dimopoulos A M; Gogas H; Skarlos D; Papacostas P; Boukovinas J; Bakogiannis Ch; Pantelakos P; Athanasiou H; Misailidou D; Tsekeris P; Pavlidis N
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Anticancer research 2007;27(6C):4391-5.
2007: Papadopoulos Savvas; Kouvatseas George; Skarlos Dimosthenis; Malamos Nikolaos; Delliou Eleftheria; Saratsiotou Ioanna; Ardavanis Alexandros; Mavroudis Dimitrios; Skarpidi Evangelia; Arapantoni Petroula; Karyda Irini; Patakioyta Frideriki; Aravantinos Gerasimos; Razis Evangelia; Fountzilas George; Kosmidis Paris
Comparison of HER2 detection methods between central and regional laboratories in Greece.
Clinical breast cancer 2007;7(10):784-90.
2007: Kosmidis Paris A; Dimopoulos Meletios-Athanasios; Syrigos Konstantinos; Nicolaides Costas; Aravantinos Gerasimos; Boukovinas Ioannis; Pectasides Dimitrios; Fountzilas George; Bafaloukos Dimitrios; Bacoyiannis Charalampos; Kalofonos Haralampos P
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(2):135-40.
2007: Makatsoris Thomas; Papakostas Pavlos; Kalofonos Haralabos P; Xanthakis Ioannis; Tsavdaridis Dimitrios; Aravantinos Gerasimos; Gogas Helen; Klouvas George; Kosmidis Paris; Pectasides Dimitrios; Fountzilas George
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.
Medical oncology (Northwood, London, England) 2007;24(3):301-7.
2006: Crawford Jeffrey; Kosmidis Paris A; Hirsch Fred R; Langer Corey J
Targeting anemia in patients with lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(7):716-25.
2006: Mauri D; Pentheroudakis G; Bafaloukos D; Pectasides D; Samantas E; Efstathiou E; Kalofonos H P; Syrigos K; Klouvas G; Papakostas P; Kosmidis P; Fountzilas G; Pavlidis N;
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
Anticancer research 2006;26(4B):3175-81.
2006: Murray S; Timotheadou E; Linardou H; Vrettou A V; Kostopoulos I; Skrickova J; Papakostantinou C; Christodoulou C; Pectasides D; Samantas E; Papakostas P; Skarlos D V; Kosmidis P; Fountzilas G
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):225-33.
2006: Onyenadum A; Gogas H; Kosmidis P; Aravantinos G; Bafaloukos D; Bacoyiannis H; Markopoulos C; Koutras A; Tzorakoelefterakis E; Makatsoris T; Fountzilas G; Kalofonos H P;
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer.
Journal of chemotherapy (Florence, Italy) 2006;18(2):192-8.
2006: Barrett-Lee Peter J; Ludwig Heinz; Birgegård Gunnar; Bokemeyer Carsten; Gascón Pere; Kosmidis Paris A; Krzakowski Maciej; Nortier Johan W R; Kongable Gail; Schneider Maurice; Schrijvers Dirk; Van Belle Simon J;
Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey.
Oncology 2006;70(1):34-48.
2005: Kosmidis Paris; Krzakowski Maciej;
Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
Lung cancer (Amsterdam, Netherlands) 2005;50(3):401-12.
2005: Fountzilas G; Skarlos D; Dafni U; Gogas H; Briasoulis E; Pectasides D; Papadimitriou C; Markopoulos C; Polychronis A; Kalofonos H P; Siafaka V; Kosmidis P; Timotheadou E; Tsavdaridis D; Bafaloukos D; Papakostas P; Razis E; Makrantonakis P; Aravantinos G; Christodoulou C; Dimopoulos A-M
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1762-71.
2005: Briasoulis E; Samantas E; Kalofonos H; Skarlos D; Makatsoris T; Christodoulou C; Fountzilas G; Bamias A; Dimopoulos M A; Kosmidis P; Pavlidis N
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Cancer chemotherapy and pharmacology 2005;56(5):521-8.
2005: Skarlos Dimosthenis V; Kalofonos Haralabos P; Fountzilas George; Dimopoulos Meletios A; Pavlidis Nicholas; Razis Evangelia; Economopoulos Theofanis; Pectasides Dimitrios; Gogas Helen; Kosmidis Paris; Bafaloukos Dimitrios; Klouvas George; Kyratzis George; Aravantinos Gerasimos
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Anticancer research 2005;25(4):3103-8.
2005: Fountzilas George; Pectasides Dimitrios; Kalogera-Fountzila Anna; Skarlos Dimosthenis; Kalofonos Haralambos P; Papadimitriou Christos; Bafaloukos Dimitrios; Lambropoulos Stefanos; Papadopoulos Savvas; Kourea Helen; Markopoulos Christos; Linardou Helen; Mavroudis Dimitrios; Briasoulis Evangelos; Pavlidis Nicholaos; Razis Evangelia; Kosmidis Paraskevas; Gogas Helen
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Breast cancer research and treatment 2005;92(1):1-9.
2005: Aravantinos G; Fountzilas G; Kosmidis P; Dimopoulos M A; Stathopoulos G P; Pavlidis N; Bafaloukos D; Papadimitriou C; Karpathios S; Georgoulias V; Papakostas P; Kalofonos H P; Grimani E; Skarlos D V;
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: Kalofonos H P; Aravantinos G; Kosmidis P; Papakostas P; Economopoulos T; Dimopoulos M; Skarlos D; Bamias A; Pectasides D; Chalkidou S; Karina M; Koutras A; Samantas E; Bacoyiannis C; Samelis G F; Basdanis G; Kalfarentzos F; Fountzilas G
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):869-77.
2005: Xiros N; Papacostas P; Economopoulos T; Samelis G; Efstathiou E; Kastritis E; Kalofonos H; Onyenadum A; Skarlos D; Bamias A; Gogas H; Bafaloukos D; Samantas E; Kosmidis P
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):773-9.
2005: Razis E; Skarlos D; Briasoulis E; Dimopoulos M; Fountzilas G; Lambropoulos S; Rigatos S; Kopterides P; Efstathiou H; Tzamakou E; Bakoyannis C; Pectasides D; Makatsoris T; Varthalitis G; Papadopoulos S; Kosmidis P
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.
Anti-cancer drugs 2005;16(2):191-8.
2005: Apessos A; Mihalatos M; Danielidis I; Kallimanis G; Agnantis N J; Triantafillidis J K; Fountzilas G; Kosmidis P A; Razis E; Georgoulias V A; Nasioulas G
hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.
British journal of cancer 2005;92(2):396-404.
2004: Bafaloukos D; Papadimitriou C; Linardou H; Aravantinos G; Papakostas P; Skarlos D; Kosmidis P; Fountzilas G; Gogas H; Kalofonos C; Dimopoulos A M
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.
British journal of cancer 2004;91(9):1639-44.
2004: Ludwig Heinz; Van Belle Simon; Barrett-Lee Peter; Birgegård Gunnar; Bokemeyer Carsten; Gascón Pere; Kosmidis Paris; Krzakowski Maciej; Nortier Johan; Olmi Patrizia; Schneider Maurice; Schrijvers Dirk
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2293-306.
2004: Fountzilas G; Kalofonos H P; Dafni U; Papadimitriou C; Bafaloukos D; Papakostas P; Kalogera-Fountzila A; Gogas H; Aravantinos G; Moulopoulos L A; Economopoulos T; Pectasides D; Maniadakis N; Siafaka V; Briasoulis E; Christodoulou C; Tsavdaridis D; Makrantonakis P; Razis E; Kosmidis P; Skarlos D; Dimopoulos M A
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1517-26.
2004: Belogianni Ioulia; Apessos Angela; Mihalatos Markos; Razi Evangelia; Labropoulos Stefanos; Petounis Andreas; Gaki Vasiliki; Keramopoulos Antonios; Pandis Nikos; Kyriacou Kyriacos; Hadjisavvas Andreas; Kosmidis Paris; Yannoukakos Drakoulis; Nasioulas Georgios
Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.
BMC cancer 2004;4():61.
2004: Kalofonos Haralabos P; Bafaloukos Dimitrios; Kourelis Theodoros G; Karamouzis Michalis V; Megas Panagiotis; Iconomou Grigorios; Tsiata Ekaterini; Dimitropoulos Dimitrios; Kosmidis Paris; Lampiris E
Adriamycin and cis-platinum as first-line treatment in unresectable locally advanced or metastatic adult soft-tissue sarcomas.
American journal of clinical oncology 2004;27(3):307-11.
2004: Bamias A; Deliveliotis Ch; Fountzilas G; Gika D; Anagnostopoulos A; Zorzou M P; Kastritis E; Constantinides C; Kosmidis P; Dimopoulos M A
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2150-4.
2004: Kosmidis Paris A
Treatment of carcinoid of the lung.
Current opinion in oncology 2004;16(2):146-9.
2004: Fountzilas George; Stathopoulos G; Kouvatseas G; Polychronis A; Klouvas G; Samantas E; Zamboglou N; Kyriakou K; Adamou A; Pectasidis D; Ekonomopoulos Th; Kalofonos H P; Bafaloukos D; Georgoulias V; Razis E; Koukouras D; Zombolas V; Kosmidis P; Skarlos D; Pavlidis N;
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
2004: Bamias A; Aravantinos G; Deliveliotis C; Bafaloukos D; Kalofonos C; Xiros N; Zervas A; Mitropoulos D; Samantas E; Pectasides D; Papakostas P; Gika D; Kourousis C; Koutras A; Papadimitriou C; Bamias C; Kosmidis P; Dimopoulos M A;
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):220-8.
2004: Razis Evangelia; Kosmidis Paris; Aravantinos Gerassimos; Bakoyiannis Charalambos; Janinis Jim; Timotheadou Helen; Christodoulou Christos; Fountzilas George
Second line chemotherapy with 5 fluorouracil and vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer.
Cancer investigation 2004;22(1):10-5.
2003: Bunn Paul A; Shepherd Frances A; Sandler Alan; Le Chevalier Thierry; Belani Chandra P; Kosmidis Paris A; Scagliotti Giorgio V; Giaccone Giuseppe
Ongoing and future trials of biologic therapies in lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S175-86.
2003: Kosmidis Paris A; Manegold Christian
Advanced NSCLC: new cytostatic agents.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S123-32.
2003: Aravantinos G; Bafaloukos D; Fountzilas G; Christodoulou C; Papadimitriou C; Pavlidis N; Kalofonos H P; Gogas H; Kosmidis P; Dimopoulos M A
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1094-9.
2003: Skarlos Dimosthenis-Vasilios; Dimopoulos Athanassios-Meletios; Kosmidis Paraskevas; Papakostas Pavlos; Pavlidis Nicholas; Bacoyiannis Charalambos; Kiamouris Christos; Klouvas Georgios; Gogas Helen; Fountzilas George; Samantas Epaminondas;
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group.
Lung cancer (Amsterdam, Netherlands) 2003;41(1):107-11.
2003: Samelis G F; Skarlos D; Bafaloukos D; Kosmidis P; Anagnostopoulos A; Aravantinos G; Dimopoulos M A;
The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Urology 2003;61(6):1211-5.
2003: Mihalatos Markos; Apessos Angela; Triantafillidis John K; Kosmidis Paris A; Fountzilas George; Agnantis Niki J; Yannoukakos Drakoulis; Nasioulas George
Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort.
Anticancer research 2003;23(3B):2691-5.
2003: Mihalatos M; Danielides I; Belogianni J; Harokopos E; Papadopoulou E; Kalimanis G; Tsiava M; Triantafillidis J K; Kosmidis P A; Fountzilas G; Basdanis G; Agnantis N J; Yannoukakos D; Nasioulas G
Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients.
Cancer genetics and cytogenetics 2003;141(1):65-70.
2002: Christodolou C; Pavlidis N; Samantas E; Fountzilas G; Kouvatseas G; Pagdatoglou K; Palamidas F; Nikolaidis C; Angelidou M; Kalofonos H P; Kosmidis P; Skarlos D V
Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
Anticancer research 2002;22(6B):3749-57.
2002: Gogas H; Papadimitriou C; Kalofonos H P; Bafaloukos D; Fountzilas G; Tsavdaridis D; Anagnostopoulos A; Onyenadum A; Papakostas P; Economopoulos T; Christodoulou C; Kosmidis P; Markopoulos C
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(11):1737-42.
2002: Kosmidis Paris; Mylonakis Nick; Nicolaides Costas; Kalophonos Charalabos; Samantas Epaminontas; Boukovinas John; Fountzilas George; Skarlos Dimosthenis; Economopoulos Theophanis; Tsavdaridis Dimitrios; Papakostas Pavlos; Bacoyiannis Charalabos; Dimopoulos Meletios
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3578-85.
2002: Malamitsi Julia; Kosmidis Paris A; Papadopoulos Savvas; Petounis Andreas; Linos Dimitrios A
Contribution of an Anti-CEA Fab' scan in the detection of medullary thyroid cancer.
Clinical nuclear medicine 2002;27(6):447-8.
2002: Foroulis Christopher N; Iliadis Kosmas H; Mauroudis Panayiotis M; Kosmidis Paris A
Basaloid carcinoma, a rare primary lung neoplasm: report of a case and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2002;35(3):335-8.
2002: Bafaloukos D; Gogas H; Georgoulias V; Briassoulis E; Fountzilas G; Samantas E; Kalofonos Ch; Skarlos D; Karabelis A; Kosmidis P
Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):420-5.
2002: Bafaloukos D; Aravantinos G; Fountzilas G; Stathopoulos G; Gogas H; Samonis G; Briasoulis E; Mylonakis N; Skarlos D V; Kosmidis P
Docetaxel in combination with dacarbazine in patients with advanced melanoma.
Oncology 2002;63(4):333-7.
2002: Bacoyiannis C; Dimopoulos M A; Kalofonos H P; Nicolaides C; Aravantinos G; Bafaloukos D; Samelis G; Onyenadum A; Kiamouris Ch; Skarlos D; Pavlidis N; Triantafillidis A; Kosmidis P;
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.
Oncology 2002;63(2):130-8.
2001: Fountzilas G; Tsavdaridis D; Kalogera-Fountzila A; Christodoulou C H; Timotheadou E; Kalofonos C H; Kosmidis P; Adamou A; Papakostas P; Gogas H; Stathopoulos G; Razis E; Bafaloukos D; Skarlos D
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1545-51.
2001: Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
Molecular and cellular probes 2001;15(5):243-7.
2001: Pectasides D; Dimopoulos M A; Aravantinos G; Kalophonos H P; Papacostas P; Briasoulis E; Cogas E; Papadimitriou C; Skarlos D; Kosmidis P; Fountzilas G
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.
Anticancer research 2001;21(5):3575-80.
2001: Skarlos D V; Samantas E; Briassoulis E; Panoussaki E; Pavlidis N; Kalofonos H P; Kardamakis D; Tsiakopoulos E; Kosmidis P; Tsavdaridis D; Tzitzikas J; Tsekeris P; Kouvatseas G; Zamboglou N; Fountzilas G
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1231-8.
2001: Fountzilas G; Papadimitriou C; Dafni U; Bafaloukos D; Skarlos D; Moulopoulos L A; Razis E; Kalofonos H P; Aravantinos G; Briassoulis E; Papakostas P; Abela K; Gogas E; Kosmidis P; Pavlidis N; Dimopoulos M A
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2232-9.
2001: Christodoulou C; Bafaloukos D; Kosmidis P; Samantas E; Bamias A; Papakostas P; Karabelis A; Bacoyiannis C; Skarlos D V;
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):249-54.
2001: Razis E; Dimopoulos A M; Bafaloukos D; Papadimitriou C; Kalogera-Fountzila A; Kalofonos H; Briassoulis E; Samantas E; Keramopoulos A; Pavlidis N; Kosmidis P; Fountzilas G
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer.
Cancer investigation 2001;19(2):137-44.
2000: Tsavaris N; Kosmas C; Mylonakis N; Bacoyiannis C; Kalergis G; Vadiaka M; Boulamatsis D; Iakovidis V; Kosmidis P
Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.
Anticancer research 2000;20(6C):4777-83.
2000: Samantas E; Kalofonos H; Linardou H; Nicolaides C; Mylonakis N; Fountzilas G; Kosmidis P; Skarlos D
Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1395-7.
2000: Briasoulis E; Kalofonos H; Bafaloukos D; Samantas E; Fountzilas G; Xiros N; Skarlos D; Christodoulou C; Kosmidis P; Pavlidis N
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3101-7.
2000: Tsavaris N; Skarlos D; Bacoyiannis C; Aravantinos G; Kosmas C; Retalis G; Panopoulos C; Vadiaka M; Dimitrakopoulos A; Kostantinidis K; Mitropoulos D; Bougas D; Pantazopoulos D; Kosmidis P
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2000;20(8):685-90.
2000: Nicolaides C; Dimopoulos M A; Samantas E; Bafaloukos D; Kalofonos C; Fountzilas G; Razi E; Kosmidis P; Pavlidis N
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):873-5.
2000: Kosmidis P; Mylonakis N; Skarlos D; Samantas E; Dimopoulos M; Papadimitriou C; Kalophonos C; Pavlidis N; Nikolaidis C; Papaconstantinou C; Fountzilas G
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):799-805.
2000: Aravantinos G; Dimopoulos M A; Kosmidis P; Bafaloukos D; Papadimitriou C; Kiamouris C; Pavlidis N; Sikiotis K; Papakostas P; Skarlos D V
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):607-12.
2000: Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Oncology 2000;58(3):227-36.
2000: Kosmidis P; Mylonakis N; Dimopoulos A; Pavlidis N; Fountzilas G; Samantas E; Dimitriadis K; Kalophonos C; Tsavdaridis D; Skarlos D
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group.
Seminars in oncology 2000;27(1 Suppl 2):3-8.
2000: Janinis J; Giannakakis T; Athanasiades A; Fountzilas G; Bafaloukos D; Kosmidis P; Nikolaides K; Pavlidis N; Skarlos D
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study.
Tumori 2000;86(1):37-41.
1999: Aravantinos G; Skarlos D V; Kosmidis P; Georgoulias V; Sgouros I; Bafaloukos D; Androulakis N; Florou S; Fountzilas G
Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy.
Critical reviews in oncology/hematology 1999;32(3):209-19.
1999: Dimopoulos M A; Bakoyannis C; Georgoulias V; Papadimitriou C; Moulopoulos L A; Deliveliotis C; Karayannis A; Varkarakis I; Aravantinos G; Zervas A; Pantazopoulos D; Fountzilas G; Bamias A; Kyriakakis Z; Anagnostopoulos A; Giannopoulos A; Kosmidis P
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1385-8.
1999: Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Oncology 1999;57(1):1-9.
1999: Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Liaros A; Athanassiou E; Dombros N; Dervenis C; Basdanis G; Gamvros O; Souparis A; Briasoulis E; Samantas E; Kappas A; Kosmidis P; Skarlos D; Pavlidis N
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):671-6.
1999: Fountzilas G; Stathopoulos G; Nicolaides C; Kalogera-Fountzila A; Kalofonos H; Nikolaou A; Bacoyiannis C; Samantas E; Papadimitriou C; Kosmidis P; Daniilidis J; Pavlidis N
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):475-8.
1999: Bafaloukos D; Aravantinos G; Samonis G; Katsifis G; Bakoyiannis C; Skarlos D; Kosmidis P
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic cooperative oncology group study.
Oncology 1999;56(3):198-201.
1999: Samantas E; Skarlos D V; Pectasides D; Nicolaides P; Kalofonos H; Mylonakis N; Vardoulakis T h; Kosmidis P; Pavlidis N; Fountzilas G
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1999;23(2):159-68.
1998: Tsavaris N; Fountzilas G; Mylonakis N; Athanassiadis A; Kosmas C; Karakousis C; Bacoyiannis C; Kosmidis P
A randomized comparative study of antiemetic prophylaxis with ondansentron in a single 32-mg loading dose versus 8 mg every 6 h in patients undergoing cisplatin-based chemotherapy.
Oncology 1998;55(6):513-6.
1998: Fountzilas G; Nicolaides C; Aravantinos G; Skarlos D; Kosmidis P; Papakostas P; Stathopoulos G P; Kontostolis E; Bafaloukos D; Pavlidis N
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.
Oncology 1998;55(6):508-12.
1998: Fountzilas G; Dimopoulos A M; Papadimitriou C; Kalogera-Fountzila A; Aravantinos G; Bafaloukos D; Athanassiades A; Nicolaides C; Keramopoulos A; Pavlidis N; Kosmidis P; Skarlos D
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1031-4.
1998: Nicolaides C; Fountzilas G; Zoumbos N; Skarlos D; Kosmidis P; Pectasides D; Karabelis A; Giannakakis T; Symeonidis A; Papadopoulos A; Antoniou F; Pavlidis N
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
Oncology 1998;55(5):405-15.
1998: Tsavaris N; Mylonakis N; Bacoyiannis C; Kosmas C; Kalergis G; Iakovidis V; Tzaninis D; Kosmidis P
Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.
Oncology reports 1998;5(5):1147-55.
1998: Kalogera-Fountzila A; Kosmidis P; Bacoyiannis C; Nicolaou A; Samantas E; Briassoulis E; Pavlidis N; Skarlos D; Daniilidis J; Fountzilas G
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer.
Anticancer research 1998;18(1B):587-93.
1998: Bafaloukos D; Fountzilas G; Skarlos D; Pavlidis N; Bakoyiannis C; Karvounis N; Kosmidis P
Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma.
Oncology 1998;55(1):48-52.
1997: Fountzilas G; Athanassiades A; Giannakakis T; Briasoulis E; Bafaloukos D; Kalogera-Fountzila A; Onienaoum A; Kalofonos H; Pectasides D; Andreopoulou E; Bamia C; Kosmidis P; Pavlidis N; Skarlos D
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1213-20.
1997: Fountzilas G; Athanassiades A; Kalogera-Fountzila A; Samantas E; Bacoyiannis C; Briassoulis E; Pavlidis N; Kosmidis P; Skarlos D
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-28-S19-32.
1997: Fountzilas G; Vasilaros S; Koukouras D; Malamos N; Pectasides D; Adamou A; Nenopoulou E; Kiriakou K; Zouvani I; Katsohis K; Kappas A; Skopa C; Semoglou C; Fahantidis E; Konstantaras C; Vasilaki E; Economopoulos T; Bacoyiannis H; Bafaloukos D; Razi E; Polichronis A; Androulakis G; Papaioannou T; Pavlidis N; Kosmidis P
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study.
Anticancer research 1997;17(6D):4681-9.
1997: Fountzilas G; Athanassiadis A; Kalogera-Fountzila A; Aravantinos G; Bafaloukos D; Briasoulis E; Dombros N; Ioannidis I; Pavlidis N; Kosmidis P; Skarlos D
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1893-5.
1997: Skarlos D V; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos G P; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Seminars in oncology 1997;24(5 Suppl 15):S15-57-S15-61.
1997: Tsavaris N; Primikirios N; Mylonakis N; Varouchakis G; Dosios T; Pavlidis N; Skarlos D; Tasopoulos T; Dritsas J; Kosmidis P
Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
Anticancer research 1997;17(5B):3799-802.
1997: Samonis G; Bafaloukos D; Margioris A N; Katsarma G; Toloudis P; Bacoyannis C; Karvounis N; Georgoulias V; Kosmidis P
First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
Oncology 1997;54(5):371-5.
1997: Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanassiadis A; Pavlidis N; Skarlos D
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.
Seminars in oncology 1997;24(4 Suppl 12):S12-30-S12-33.
1997: Kosmidis P A; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Andreopoulou E; Pavlidis N; Skarlos D
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):697-9.
1997: Fountzilas G; Kosmidis P; Avramidis V; Nikolaou A; Kalogera-Fountzila A; Makrantonakis P; Bacoyiannis C; Samantas E; Skarlos D; Daniilidis J
Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic Co-operative oncology Group study.
Medical and pediatric oncology 1997;28(6):401-10.
1997: Fountzilas G; Skarlos D; Athanassiades A; Kalogera-Fountzila A; Samantas E; Bacoyiannis C; Nicolaou A; Dombros N; Briasoulis E; Dinopoulou M; Stathopoulos G; Pavlidis N; Kosmidis P; Daniilidis J
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):451-5.
1997: Kosmidis P A; Bacoyiannis C; Fountzilas G; Aravantinos G; Tsavaris N; Milathianakis C; Skarlos D
5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):373-8.
1997: Fountzilas G; Athanassiadis A; Samantas E; Skarlos D; Kalogera-Fountzila A; Nikolaou A; Bacoyiannis H; Stathopoulos G; Kosmidis P; Daniilidis J
Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
Seminars in oncology 1997;24(1 Suppl 2):S2-65-S2-67.
1997: Aravantinos G; Skarlos D V; Kosmidis P; Athanassiades A; Bafaloukos D; Giannakakis T; Karpathios S; Fountzilas G
A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group study.
European journal of cancer (Oxford, England : 1990) 1997;33(1):160-3.
1996: Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Skarlos D
Paclitaxel and carboplatin in inoperable non-small cell lung cancer.
Seminars in oncology 1996;23(6 Suppl 16):68-70.
1996: Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Skarlos D
Paclitaxel and carboplatin in nonoperable non-small cell lung cancer.
Seminars in oncology 1996;23(6 Suppl 15):16-8.
1996: Tsavaris N; Baxevanis C; Kosmidis P; Papamichael M
The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon alpha 2b.
Cancer immunology, immunotherapy : CII 1996;43(2):94-102.
1996: Kosmidis P A; Tsavaris N; Skarlos D; Theocharis D; Samantas E; Pavlidis N; Briassoulis E; Fountzilas G
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2682-7.
1996: Tsavaris N B; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekois D; Tsetis A; Klonaris C
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
American journal of clinical oncology 1996;19(5):517-21.
1996: Kosmidis P; Mylonakis N; Fountzilas G; Pavlidis N; Samantas E; Karabelis A; Kattis K; Skarlos D
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):517-20.
1996: Bafaloukos D; Pavlidis N; Fountzilas G; Skarlos D; Klouvas G; Makrantonakis P; Giannakakis T; Tsavaris N; Kosmidis P
Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma.
American journal of clinical oncology 1996;19(3):296-300.
1996: Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
American journal of clinical oncology 1996;19(3):271-7.
1996: Tsavaris N; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekas D; Tsetis A; Klonaris C
A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.
Chemotherapy 1996;42(3):220-6.
1996: Skarlos D V; Aravantinos G; Kosmidis P; Pavlidis N; Gennatas K; Beer M; Mylonakis N; Makrantonakis P; Klouvas G; Karpathios S; Linardou H; Konstantaras C; Fountzilas G
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):421-8.
1996: Pavlidis N; Nicolaides C; Athanassiadis A; Beriatou K; Skarlos D; Giannakakis T; Kosmidis P; Karvounis N; Fountzilas G
Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):159-62.
1996: Fountzilas G; Polichronis A; Katsohis K; Gennatas K; Toussis D; Skarlos D; Kosmidis P; Vassilaros S; Semoglou C; Giannakakis T; Fahantidis E; Klouvas G; Tsavaris N; Konstantaras C; Makrantonakis P; Kolotas C; Zamboglou N; Tsiliakos S; Hainoglou D; Mylonakis N; Pavlidis N
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):137-46.
1996: Fountzilas G; Athanassiades A; Giannakakis T; Bafaloukos D; Karakousis K; Dombros N; Kosmidis P; Skarlos D
A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines.
European journal of cancer (Oxford, England : 1990) 1996;32A(1):47-51.
1996: Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
Cancer chemotherapy and pharmacology 1996;38(3):292-7.
1996: Fountzilas G; Kosmidis P; Sridhar K S; Kalogera-Fountzila A; Banis K; Dimitriadis A; Avramidis V; Nikolaou A; Zaramboukas T; Skarlos D; Vritsios A; Daniilidis I
Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group study.
Cancer investigation 1996;14(3):189-96.
1995: Fountzilas G; Skarlos D; Nikolaou A; Kalogera-Fountzila A; Tzitzikas J; Kosmidis P; Makrantonakis P; Samantas E; Karpasitis N; Bacoyiannis H
Radiation and concurrent carboplatin administration in locally advanced head and neck cancer. A Hellenic Cooperative Oncology Group Study.
Tumori 1995;81(5):354-8.
1995: Tsavaris N; Tentas K; Bacoyiannis C; Katsikas M; Sakelaropoulos N; Kosmas C; Daliani D; Kosmidis P
5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer: a pilot study.
Anti-cancer drugs 1995;6(4):599-603.
1995: Tsavaris N; Mylonakis N; Bacoyiannis C; Karvounis N; Charalambidis G; Pagou M; Lioni A; Daliani D; Kosmidis P
Efficacy of ondansetron treatment with different timing schedules: a randomized double-blind study.
Oncology 1995;52(4):315-8.
1995: Tsavaris N; Foutzilas G; Markantonakis P; Mylonakis N; Bacoyannis C; Zisiadis A; Basdanis G; Karvounis N; Sobolos K; Kosmidis P
A comparative study with two administration schedules of leucovorin and 5-fluorouracil in advanced colorectal cancer.
Journal of chemotherapy (Florence, Italy) 1995;7(1):71-7.
1995: Tsavaris N B; Tsaroucha-Noutsou E; Karvounis N; Bacoyannis C; Pagou M; Kosmidis P
Comparison of different schedules of ondansetron (GR 38032F) administration during cisplatin-based chemotherapy: a randomized trial.
Chemotherapy 1995;41(1):70-6.
1995: Fountzilas G; Skarlos D; Katsohis C; Pavlidis N; Giannakakis T; Bafaloukos D; Fahantidis E; Klouvas G; Beer M; Kosmidis P
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group study.
Medical and pediatric oncology 1995;24(1):23-8.
1995: Tsavaris N; Charalambidis G; Ganas N; Pagou M; Karabellis A; Mylonakis N; Benou N; Tsikalakis D; Kosmidis P
Ondansetron versus metoclopramide as antiemetic treatment during cisplatin-based chemotherapy. A prospective study with special regard to regard to electrolyte imbalance.
Acta oncologica (Stockholm, Sweden) 1995;34(2):243-6.
1995: Tsavaris N; Baxevanis K; Kosmidis P; Papamichael M
The prognostic significance of immune changes in patients with renal cancer and melanoma treated with interferon-alpha 2b.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1995;16(6):365-73.
1994: Tsavaris N; Charalambidis G; Pagou M; Karabelis A; Mylonakis N; Bacoyiannis C; Kosmidis P
Comparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapy.
American journal of clinical oncology 1994;17(6):516-21.
1994: Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
Lung cancer (Amsterdam, Netherlands) 1994;11(5-6):353-64.
1994: Skarlos D V; Samantas E; Kosmidis P; Fountzilas G; Angelidou M; Palamidas P; Mylonakis N; Provata A; Papadakis E; Klouvas G
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(7):601-7.
1994: Tsavaris N; Mylonakis N; Karvounis N; Bacoyiannis C; Briasoulis E; Skarlos D; Pavlidis N; Stamatelos G; Kosmidis P
Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma.
Lung cancer (Amsterdam, Netherlands) 1994;11(3-4):299-303.
1994: Fountzilas G; Kosmidis P; Zamboglou N; Nikolaou A; Banis K; Avramidis V; Vritsios A; Daniilidis J
Does substitution of surgery with induction chemotherapy preserve organ function in inoperable head and neck cancer? A retrospective analysis of 73 cases.
Journal of chemotherapy (Florence, Italy) 1994;6(4):272-8.
1994: Kosmidis P A; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Seminars in oncology 1994;21(3 Suppl 6):23-30.
1994: Tsavaris N; Mylonakis N; Bacoyiannis C; Katsikas M; Lioni A; Kosmidis P
Comparison of ondansentron versus ondansentron plus methylprednisolone as antiemetic prophylaxis during cisplatin-containing chemotherapy.
Journal of pain and symptom management 1994;9(4):254-8.
1994: Kosmidis P; Mylonakis N; Skarlos D V; Samantas E; Beer M; Theocharis D; Zachariadis E; Gioti A; Papadakis E; Poulakis N
A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung Cancer Trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(2):159-62.
1994: Fountzilas G; Skarlos D; Kosmidis P; Samantas E; Kalogera-Fountzila A; Papaspyrou S; Tzitzikas J; Sridhar K S; Makrantonakis P; Pantelakos P
Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer. A Hellenic Co-operative Oncology Group study.
Acta oncologica (Stockholm, Sweden) 1994;33(7):825-30.
1994: Fountzilas G; Skarlos D; Giannakakis T; Athanasiades A; Bafaloukos D; Kalogera-Fountzila A; Bamia C; Pavlidis N; Kosmidis P
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):965-9.
1994: Pavlidis N; Kalef-Ezra J; Briassoulis E; Skarlos D; Kosmidis P; Saferiadis K; Bairaktari E; Bafaloukos D; Maravegias A; Theoharis D
Evaluation of six tumor markers in patients with carcinoma of unknown primary.
Medical and pediatric oncology 1994;22(3):162-7.
1993: Tsavaris N; Mylonakis N; Bacoyiannis C; Tsoutsos H; Karabelis A; Kosmidis P
Treatment of renal cell carcinoma with escalating doses of alpha-interferon.
Chemotherapy 1993;39(5):361-6.
1993: Tsavaris N; Vonorta K; Tsoutsos H; Kozatsani-Halividi D; Mylonakis N; Papagrigoriou D; Koutsiouba-Kazakou P; Kosmidis P
Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC).
The International journal of biological markers 1993;8(2):88-93.
1993: Bafaloukos D; Samonis G; Klinaki A; Daliani D; Karvounis N; Bacoyiannis C; Karabelis A; Milonakis N; Kosmidis P
First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):851-3.
1993: Skarlos D V; Fountzilas G; Pavlidis N; Beer M; Makrantonakis P; Aravantinos G; Pantelakos P; Tsavaris N; Karpasitis N; Kosmidis P
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study.
Acta oncologica (Stockholm, Sweden) 1993;32(1):37-41.
1992: Pavlidis N; Kosmidis P; Skarlos D; Briassoulis E; Beer M; Theoharis D; Bafaloukos D; Maraveyas A; Fountzilas G
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(8):631-4.
1992: Kosmidis P A; Baxevanis C N; Tsavaris N; Papanastasiou M; Anastasopoulos E; Bacoyiannis C; Mylonakis N; Karvounis N; Bafaloukos D; Karabelis A
The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon alfa-2b.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1153-7.
1992: Fountzilas G; Kosmidis P; Beer M; Sridhar K S; Banis K; Vritsios A; Daniilidis J
Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy. A Hellenic Co-operative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(7):553-8.
1992: Tsavaris N; Tsigalakis D; Bobota A; Tsoutsos E; Sarafidou M; Papazachariou M; Komitsopoulou P; Kosmidis P
Prognostic value of serum levels of immunoglobulins (IgA, IgM, IgG, IgE) in patients with colorectal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1992;18(1):31-6.
1992: Mylonakis N; Tsavaris N; Bacoyiannis C; Karvounis N; Kakolyris S; Karabelis A; Beer M; Kosmidis P
A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(2):127-30.
1992: Tsavaris N B; Komitsopoulou P; Karagiaouris P; Loukatou P; Tzannou I; Mylonakis N; Kosmidis P
Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach.
Cancer chemotherapy and pharmacology 1992;30(4):330-3.
1992: Tsavaris N; Tzannou I; Karvounis N; Kosmidis P
Continuous 24-hour infusion of folinic acid does not increase the response rate of 5-fluorouracil but only the toxicity.
Oncology 1992;49(2):154-6.
1992: Tsavaris N; Tsaroucha-Noutsou E; Bacoyannis C; Mylonakis N; Valilis P; Kozatsani-Halividi D; Tsoutsos H; Droufakou S; Kosmidis P
Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial.
Oncology 1992;49(6):479-83.
1991: Tsavaris N; Zinelis A; Tsoutsos H; Kosmidis P
The response of paraneoplastic fever of lymphomas and solid tumours to the administration of naproxen.
Journal of internal medicine 1991;230(6):549-50.
1991: Tsavaris N; Zamanis N; Zinelis A; Tsoutsos E; Mylonakis N; Bacoyannis C; Valilis P; Sarafidou M; Kosmidis P
Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin.
Journal of pain and symptom management 1991;6(8):461-5.
1991: Nikolaou A; Fountzilas G; Kosmidis P; Banis C; Sobolos K; Daniilidis J
Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy before local treatment.
The Journal of laryngology and otology 1991;105(11):930-3.
1991: Fountzilas G; Kosmidis P; Makrantonakis P; Sridhar K S; Banis K; Themelis C; Kalogera-Fountzila A; Avramidis V; Beer M; Sombolos K
Carboplatin, continuous infusion fluorouracil and mid-cycle high-dose methotrexate as initial treatment in patients with locally advanced head and neck cancer. Hellenic Co-operative Oncology Group Study.
Tumori 1991;77(5):426-31.
1991: Fountzilas G; Daniilidis J; Kosmidis P; Sridhar K S; Kalogera-Fountzila A; Banis K; Avramidis V; Tsavdaridis D; Themelis C; Zaramboukas T
Platinum-based induction chemotherapy followed by radiation as definitive treatment for patients with locally advanced cancer of the oral cavity, oropharynx and hypopharynx. A retrospective analysis of 32 cases.
Journal of chemotherapy (Florence, Italy) 1991;3(3):183-8.
1991: Fountzilas G; Skarlos D; Pavlidis N A; Makrantonakis P; Tsavaris N; Kalogera-Fountzila A; Giannakakis T; Beer M; Kosmidis P
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group study.
Tumori 1991;77(3):232-6.
1991: Fountzilas G; Zisiadis A; Kosmidis P; Basdanis G; Makrantonakis P; Paspatis A; Tsavdaridis D; Tsavaris N; Aletras O; Tourkantonis A
High-dose leucovorin, fluorouracil and oral dipyridamole in the treatment of advanced colorectal cancer.
Anticancer research 1991;11(2):865-8.
1991: Tsavaris N; Tsoutsos H; Bacoyannis C; Mylonakis N; Karvounis N; Kozatsani-Halividi D; Tsaroucha-Noutsou E; Klinaki A; Kosmidis P
Antiemetic efficacy of alprazolam in carboplatin-induced emesis.
Chemotherapy 1991;37(5):364-70.
1991: Tsavaris N B; Komitsopoulou P; Tzannou I; Loucatou P; Tsaroucha-Noutsou A; Kilafis G; Kosmidis P
Decreased oral toxicity with the local use of allopurinol in patients who received high dose 5-fluorouracil.
Selective cancer therapeutics 1991;7(3):113-7.
1991: Fountzilas G; Daniilidis J; Kosmidis P; Sridhar K S; Kalogera-Fountzila A; Nicolaou A; Makrantonakis P; Banis K; Dimitriadis A; Sombolos K
Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer. A retrospective analysis of 39 cases.
Acta oncologica (Stockholm, Sweden) 1991;30(7):831-4.
1990: Kosmidis P A; Bacoyiannis C; Hatzichristou H
Combination chemotherapy with cis-platinum, adriamycin, mitomycin-C (PAM) in patients with advanced bladder cancer.
Journal of chemotherapy (Florence, Italy) 1990;2(6):397-400.
1990: Tsavaris N; Zinelis A; Karabelis A; Beldecos D; Bacojanis C; Milonacis N; Karvounis N; Kosmidis P
A randomized trial of the effect of three non-steroid anti-inflammatory agents in ameliorating cancer-induced fever.
Journal of internal medicine 1990;228(5):451-5.
1990: Tsavaris N; Zinelis A; Karvounis N; Beldecos D; Mylonacis N; Zamanis N; Bacoyannis C; Valilis P; Antonopoulos A; Kosmidis P
Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol.
Journal of chemotherapy (Florence, Italy) 1990;2(2):123-6.
1990: Kosmidis P A; Kondylis D; Lissaios B
Salvage chemotherapy for breast cancer patients treated with adjuvant adriamycin-containing regimen.
Oncology 1990;47(1):1-3.
1990: Tsavaris N; Bacoyannis C; Milonakis N; Sarafidou M; Zamanis N; Magoulas D; Kosmidis P
Folinic acid plus high-dose 5-fluorouracil with allopurinol protection in the treatment of advanced colorectal carcinoma.
European journal of cancer (Oxford, England : 1990) 1990;26(10):1054-6.
1990: Tsavaris N B; Pangalis G A; Variami E; Karabelis A; Kosmidis P; Raptis S
Association of neutrophil alkaline phosphatase activity and glycosylated haemoglobin in diabetes mellitus.
Acta haematologica 1990;83(1):22-5.
1988: Tsavaris N B; Kosmidis P A; Delides G S; Delides A; Papaioanou D; Pavlakis E; Lissaios B; Zaharakis M
Correlation of histoenzymological studies with the response to chemotherapy and survival in breast cancer patients.
Cancer letters 1988;42(3):225-30.
1988: Tsavaris N; Caragiauris P; Kosmidis P
Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1988;14(5):405-6.
1987: Kosmidis P A; Fountzilas G; Athanassiou A; Karabelis A; Mylonakis N; Tsavaris N; Karvounis N; Bacojiannis C
Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(6):393-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Paris Kosmidis

Research Profile (preview)

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Paris Kosmidis (preview)

All Publications